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ABSTRACT                        Cytochrome b561 (Cyt-b561) proteins constitute a family of integral membrane 
proteins, catalyzing ASC-driven trans-membrane electron transport. Numerous isoforms of Cyt-
b561 are present in invertebrates, vertebrates, and plants. The only protein of this family, how-
ever, which has been characterized in details at both biophysical, biochemical and physiological 
levels so far, is the bovine chromaffin granule Cyt-b561 (CGCyt-b561). Recently, both the bovine 
and the mouse CGCyt-b561 has been expressed in yeast cells and the recombinant proteins 
were shown to have biophysical properties similar to the native bovine CGCyt-b561. We have 
expressed the mouse CGCyt-b561 with a His6-tag at the C terminus (CGCyt-b561(C6H)) in yeast 
(Saccharomyces serevisiae) cells and studied the reduction of CGCyt-b561(C6H) in the presence 
of different natural reducing agents. Besides the well-known natural reductant ascorbate (ASC) 
and the often-used artificial reductant dithionate, NADH, GSH, and dihydrolipoic acid (DHLA), 
also reduced the fully oxidized protein. Interestingly however, NADPH was not effective at all. 
When the same reductants were tested with the R72A mutant of CGCyt-b561(C6H), a mutant 
with impaired ASC-dependent reducibility, neither pyridine-dinucleotides could reduce the R72A 
mutant. DHLA-dependent and ASC-dependent reduction kinetics were very similar in case of 
the R72A mutant but differed in case of CGCyt-b561. These results raise the question of how 
many natural reductants the CGCyt-b561 may utilize in vivo.
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Substrate-dependent reduction of a recombinant 
chromaffin granule Cyt-b561 and its R72A mutant
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Cytochromes b561 (Cyts-b561) constitute a newly described 
family of membrane proteins, present in both plants and 
animals (Asard et al. 2001; Tsubaki et al. 2005). Cyts-b561 
contain two b-type heme molecules per molecule of protein 
(Tsubaki et al. 1997). There are 6 trans-membrane (TM) 
α-helices in Cyts-b561 and TM2 through TM5 define the 
so-called CB domain (Pointing 2001). One His residue on 
each α-helix of the CB domain is highly conserved and par-
ticipates in coordination of the two hemes (Okuyama et al. 
1998). Structure prediction studies indicate that, CGCyt-b561 
follows the “Four-helix motif” (Lancaster 2002), where the 
extravesicular heme is coordinated by His residues on TM3 
and TM5, and the intra vesicular heme is coordinated by His 
residues on TM2 and TM4 (Bashtovyy 20003). 
Cyt-b561 of the chromaffin granules (CGCyt-b561) is the 
best-characterized member of the Cyt-b561 protein family. 
CGCyt-b561 is able to mediate trans-membrane electron 
transfer from ASC present on the extra-vesicular side to 
monodehydroascorbate (MDHA) present on the intra-vesicu-
lar side of the protein (Kent and Fleming 1987; Fleming and 
Kent 1991). Two regions of CGCyt-b561 have been identified 
as putative substrate binding sites, the partially conserved 
region 69ALLVYRVFR74 (numbering is for the bovine CG-
Cyt-b561) present at the end of TM2 helps in ASC binding 
while the well-conserved motif of 120SLHSW125, present on 
the intra-vesicular side of CGCyt-b561 presumably aids in 
binding of MDHA. Chemical modification studies on bovine 
CGCyt-b561, by treating the protein with diethyl-pyrocarbon-
ate (DEPC) showed the importance of His residues in mediat-
ing trans-membrane electron transfer. DEPC has the ability to 
interact with His, Lys and Tyr residues and covalently modify 
them. CGCyt-b561, treated with DEPC, had altered proper-
ties with respect to substrate binding. Mass spectrometry 
revealed that H88, H159, and K85 in the bovine CGCyt-b561 
were modified. To His residues were assigned a role in the 
coordination of extra-vesicular heme and K85 was thought 
to be involved in ASC binding (Tsubaki et al. 2000). Recent 
studies with recombinant mouse CGCyt-b561 revealed the 
importance of an Arg residue (R72 in the mouse CGCyt-b561 
sequence) in ASC-dependent reduction of the protein as well 
as identified the essential His residues coordinating the two 
hemes and responsible for the optical properties of CGCyt-
b561 (Bérczi et al. 2005).
In the near past, new members of the Cyt-b561 protein 
family were identified. One such protein is the so-called 
duodenal Cyt-b561 (DCyt-b561) was identified by subtractive 
cloning strategy (McKie et al. 2001). DCyt-b561 was shown 
to localize at the brush border membranes of the duodenum 
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and exhibited ferric reductase activity when transiently ex-
pressed in Xenopus oocytes and in intestinal cell lines (McKie 
et al. 2001). Other new member of the Cyt-b561 protein 
family includes the lysosomal Cyt-b561 (LCyt-b561), named 
after its localization in lysosomes of macrophages and sertoli 
cells. LCyt-b561 is similar to CGCyt-b561 in spectral charac-
teristics and is possibly involved in iron metabolism (Deliang 
Zhang and Han Asard, personal communication). A fourth 
isoform, tentatively named “tumor suppressor Cyt-b561” 
(gene name:101F6, herein abbreviated as TSCyt-b561) was 
identified in the 120kb tumor homozygous deletion region 
of chromosome 21 found in breast and lung cancers (Ji et al. 
2002). Over-expression of TSCyt-b561 inhibited tumor cell 
growth by induction of apoptosis and altering cell cycle pro-
gression. The biochemical characterization and understanding 
the localization and physiological function of these newly 
identified Cyts-b561 are awaited. 
Based on primary sequence conservation and predicted 
structural features, four putative Cyt-b561 genes have been 
identified in Arabidopsis thaliana (Asard et al. 2001). Al-
though there is limited homology between the predicted plant 
and animal sequences (approximately 30%), the presence 
of certain conserved residues and structural features sup-
port the similarity between the functions of these proteins. 
One of plant Cyts-b561 has already been over-expressed in 
yeast (Saccharomyces serevisiae) cells and the recombinant 
protein has been characterized to some extent (Griesen et 
al. 2004). The protein seems to be localized at the plant 
tonoplast (TCyt-b561) and encodes for an ASC-reducible 
Cyt-b561 with absorbance characteristics similar to that of 
CGCyts-b561. Presence of a Cyt-b561 in plant tonoplast was 
also obtained by characterizing an ASC-reducible b-type 
cytochrome in tonoplast-enriched bean membrane fraction 
(Preger et al. 2005). 
Hardly any is known about the substrate specificity 
of Cyts-b561. The only study in this respect was done by 
Terland and Flatmark (1980) on highly-purified chromaffin 
granule ghosts from bovine adrenal medulla. It was shown 
that less than 1% of CGCyt-b561 was reduced by 0.1 mM 
NADH at pH 6.5 in 2 min. It is shown in this paper that the 
highly-purified recombinant mouse CGCyt-b561 can be 
reduced by millimolar concentrations of natural reductants, 
and dihydrolipoic acid (DHLA) seems to be as effective 
reductant as ASC. 
Materials and Methods
Molecular biology works
Yeast expression vector pESC-His containing the mouse 
CGCyt-b561 gene (Bérczi et al. 2005) was used as a template 
for PCR reactions to generate N and C-terminal His-tagged 
proteins. Primers were designed as given by Liu et al. (2005). 
Standard PCR methods were used to amplify the gene and 
amplified sequences were confirmed by DNA-sequencing at 
the University of Nebraska – Lincoln Genomic Core Research 
Facility.
For transformation, yeast cells (Saccharomyces cerevisiae, 
strain YPH499, ura3-52 lys-801amber ade2-101ochre trp1-Δ63 
his3Δ200 leu2-Δ1) were grown in synthetic dextrose minimal 
medium (YPAD, Stratagene, La Jolla, CA) and transforma-
tion was performed according to manufactures instructions. 
Transformed lines were selected on SD dropout medium, 
lacking His (SD-His). For the induction of protein expression, 
overnight cultures were grown in SD-His, and transferred 
to 450 ml of synthetic galactose minimal medium (SG-His) 
containing 2% (w/v) galactose.
Yeast membrane preparation and stripping
Cells grown as 4 x 450 ml cultures were collected by low-
speed centrifugation (5,000 g
max
 and room temperature for 10 
min) when the OD
600










ASC (25 mM, ref.) 100 100 +320
ASC 75 ± 6 71 ± 1 +320 (b)
GSH 18 (a) 11 (a) –230 (c)
DHLA 75 ± 5 69 (a) –320 (d)
NADH 24 ± 5 0 –330 (c)
NADPH 0 0 –330 (c)
DTH 158 ± 6 122.2 ± 1 –480 (e)
Table 1. Effect of reductants on purified recombinant mouse 
CGCyt-b561 and its R72A mutant. For reference values, reduc-
tion at 25 mM of ASC is given as 100%; the 100% refers to 2.45 
± 0.75 nmol mg–1 and 1.20 ± 0.45 nmol mg–1 for CGCyt-b561 and 
its R72A mutant, respectively. All other measurements were at 
2.5 mM of reducing agents. Values are means ± deviation from 
the means of two independent experiments.
(a) measured only once
(b) Washko et al. (1992), (c) Foyer and Noctor (2005), (d) Moini et al. (2002), 
(e) Mayhew (1978),
“Apparent binding constant” for the




Wild ASC 0.021 ± 0.006 1.50 ± 0.50
DHLA 0.071 ± 0.020 -
R72A ASC - 1.48 ± 0.14
DHLA - 1.56 ± 0.10
Table 2. Kinetic constants obtained from data analysis of con-
centration dependent reduction by ASC and DHLA of CGCyt-
b561 (Wild) and its R72A mutant (Fig. 1). Data analysis was 
performed with Origin5.0 software. Values are for the best fit 
to the experimental points with their uncertainty provided by 
Origin5.0.
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cells were washed once with ice-cold homogenization buf-
fer (50 mM MOPS-KOH, pH 7.0, 5 mM EDTA, 100 mM 
KCl, 100 mM sucrose) and pelleted as above. Microsomal 
membrane preparation and stripping of membranes were as 
described recently by Bérczi et al. (2005). Stripped mem-
brane fractions were re-suspended in storage buffer (20 mM 







O, pH 6.8, 2% (w/v) glycerol), and stored at 
–80°C until use. 
Protein solubilization and purification by affin-
ity chromatography
Membrane vesicles (about 80 mg protein) were resuspended 






O, pH 6.8, 2% (w/v) glycerol, 1% 
(w/v) sucrose monolaurate (SML) at 2 mg ml-1 protein con-
centration. The mixture was incubated on a rocker at room 
temperature for a period of 60-90 min. Insoluble material 
was pelleted by high-speed centrifugation (Beckman Avanti 
centrifuge, JA-25.50 rotor) at 75,000 g
max
 and 4°C for 90 min. 
The supernatant containing the detergent-solubilized proteins 
was supplemented with 500 mM NaCl and 10 mM imidazole, 
the pH was adjusted to 7.8 and then mixed with 1 ml (bed vol-
ume) of Ni-NTA agarose resin (Ni-NTA His-bind Superflow, 







O, pH 7.8, containing 10% (w/v) glyc-
erol, 1%(w/v) SML, 500 mM NaCl and 10 mM imidazole. 
The agarose resin was incubated with the solubilized proteins 
at room for 60 min. After incubation, the Ni-NTA agarose 
resin with bound proteins was collected in a 5-ml disposable 







O, pH 7.8, containing 10% (w/v) glycerol, 0.1% 
(w/v) SML, 500 mM NaCl and 10 mM imidazole. His-tagged 







O, pH 7.0, containing 10% (w/v) glycerol, 0.1%(w/v) 
SML, 150 mM NaCl and 250 mM imidazole. The eluate 
was concentrated by centrifugation using Centricon-YM100 
centrifugal filter unit (Millipore, Bedford, MA) and desalted 
by using a PD-10 desalting column (Amersham Biosciences, 
Uppsala, Sweden). The desalted fraction was concentrated 
again and stored at –80°C until use.
Absorption spectroscopy
Absorption spectra were recorded in split beam mode (with 
buffer as reference) with an OLIS-updated SLM-Aminco 
DW2000 spectrophotometer (OLIS Co., Bogart, GA) with 
1 nm slit-width, 0.5 nm s-1 scan rate, and under continuous 
stirring. First, Cyts were oxidized by addition of ferricyanide 
(0.5 mM, FeCN) and the fully oxidized spectra were recorded. 
Then, ASC-reduced (25 mM ASC) and ASC +dithionite-re-
duced (after addition of Na-dithionite crystals) spectra were 
obtained at room temperature. When improvement of the 
signal to noise ratio was needed, multiple scans were aver-
aged. Cyt b amounts were calculated from the reduced-mi-
nus-oxidized difference spectra, obtained by subtracting the 
FeCN oxidized spectra from the ASC- or dithionite-reduced 
spectra, using a millimolar extinction coefficient of 30 mM-1 
cm-1 (Tsubaki et al. 1997; Liu et al. 2005). 
Results and Discussion
Although the major property of members of the Cyt-b561 
protein family is their ASC-reducibility, hardly any work is 
known for studying the effect of other native and putative re-
ducing agents present together with ASC in cells. Reason for 
this might be rooting in the facts that no pyridine nucleotide-
binding site can be identified in any Cyt-b561 sequences and 
midpoint redox potentials for the most common reductants 
Figure 1. Concentration-dependent reduction by ASC or DHLA of 
highly-purified recombinant CGCyt-b561 (Wild) and its R72A mutant 
(R72A). For comparison, results are shown as percentage reduction 
of proteins. Experimental results are means from two independent 












Figure 2. Chemical structure for ascorbic acid (ASC) and dihydrolipoic 
acid (DHLA) in their undissiociated forms. Arrows indicate the –SH and 
–OH groups discussed in the text.
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in the cytosol are hundreds of millivolts lower than that for 
Cyts-b561. 
Earlier studies on intact chromaffin secretory vesicles 
indicated that intra-granular ASC is regenerated by extra-
granular ASC, however, other reducing agents, such as GSH, 
NADH and NADPH did not support this process (Dhariwal 
et al. 1991). Also, the ability of serotonin-containing dense 
granules of platelets, to accept electrons from NADH and 
NADHP were studied.  Since serotonin-containing granule 
resembles that of chromaffin granules, the reduction was 
compared to CGCyt-b561 (Johnson and Scarpa 1981). In 
this study it was found that NADH could donate electrons to 
CGCyt-b561, but at a slower rate when compared to ASC. 
NADPH was unable to supply electrons. The ability of such 
physiologically relevant reducing agents to donate electrons 
to purified CGCyt-b561 has not yet been documented. Using 
the purified recombinant CGCyt-b561, the ability of NADH, 
NADPH, GSH, DHLA and dithionite (DTH) to reduce the 
CGCyt-b561 was tested.
Table 1 summarizes our results obtained when reduction 
of both FeCN-oxidixed recombinant mouse CGCyt-b561 and 
its R72A mutants were studied in the presence of 2.5 mM of 
both native and artificial reducing agents. It is clear that GSH 
as well as pyridine nucleotides are bad reducing agents for 
CGCyt-b561 but dithiol-containing reagents are capable of 
reducing both CGCyt-b561 and its R72A mutant. The physi-
ological amounts of GSH in the cells vary from 0.5 mM to 10 
mM (Wu et al. 2004) and that of NADH and NADPH vary 
from µM to mM range (Kirsch and de Groot 2001). Therefore 
the relevance of the observed reductions of CGCyt-b561 
should be interpreted cautiously, as the values for NAD(P)H 
used (2.5 mM) are relatively high when compared to physi-
ological levels. DHLA is present in mM concentrations in 
cells and is synthesized both in plants and animals (Packer et 
al. 1995; Moini et al. 2002). It is particularly interesting that 
(1) DHLA is as effective as ASC and (2) reduction by NADH 
is lost when R72 is replaced by A. This latter observation adds 
some emphasis to the predicted importance of R72 in the re-
duction mechanism of CGCyt-b561. There is not correlation 
between the reducing efficacy and midpoint redox potential 
of reductants tested. 
It has been shown recently (Bérczi et al. 2005) that R72 
seems to be responsible for the high-affinity ASC-binding 
of CGCyt-b561. It was concluded from (a) the lack of ASC-
reducibility of R72A-CGCyt-b561 below 0.1 mM of [ASC] 
and (b) the kinetic parameters of data analysis. Concentra-
tion-dependent reduction of R72A-CGCyt-b561 by DHLA 
was very similar to that by ASC (Fig. 1). DHLA seems to 
have no low-affinity binding to CGCyt-b561. Data analysis 
of experiments (Table 2) revealed that reduction by ASC and 
DHLA might follow similar kinetics and reduction of R72A-
CGCyt-b561 occurs only via low-affinity bindings of reduc-
tants. It is believed that reducing activity of DHLA resides in 
its –SH groups. Comparing (a) the chemical structure of ASC 
and DHLA (Fig. 2), (b) the midpoint redox potential values of 
ASC and DHLA (Table 1), and observing (c) the very similar 
reduction kinetics with these two reductants and the R72A 
mutant (Fig. 1), and (d) the slight difference between the 
high-affinity binding constants for ASC and DHLA, it might 
be probable that redox reactions at low reductant concentra-
tions occur via specific interactions between the reductants 
and CGCyt-b561; for instance, R72 interacts with the two 
–SH groups on DHLA in a similar way as it does with the two 
–OH groups on ASC. Further studies are needed to clarifying 
the reduction mechanism by either ASC or DHLA. 
In summary, it is shown that affinity-purified recombinant 
mouse CGCyt-b561 and its R72 mutant can be reduced not 
only by ASC (and DTH) but also by other native reductants. 
The reducing mechanism by DHLA shows similar properties 
to that by ASC. In both cases, an Arg residue in the predicted 
ASC-binding motive (R72) seems to play a key role in the 
high-affinity reduction of CGCyt-b561. 
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